Publications

(Displaying in Reverse Chronological Order)

  1. Research
  2. Publications
  3. Publications
1516
Ghagargunde KG, Sidana J and Singh IP. HPTLC fingerprinting and quantification of phenolics in Brahmarasayana - An Ayurvedic rejuvenator Analytical Chemistry Letters 2011, 1, 123-129.
1517
Ghoshal G, Kamble A, Shivhare US and Banerjee UC. Optimization of culture conditions for the production of Xylanase in submerge fermentation by Penicillium Citrinum using response surface methodology International Journal of Research and Reviews in Applied Sciences 2011, 6, 132-137.
1518
Guchhait SK and Madaan C. Groebke-Blackburn-Bienaymé multicomponent reaction in scaffold-modification of adenine, guanine, and cytosine: synthesis of aminoimidazole-condensed nucleobases Tetrahedron Letters 2011, 52, 56-58.
1519
Guchhait SK, Kashyap M and Kamble H. ZrCl(4)-Mediated Regio- and Chemoselective Friedel-Crafts Acylation of Indole Journal of Organic Chemistry 2011, 76, 4753-4758.
1520
Gupta A, Bisht B and Dey CS. Peripheral insulin-sensitizer drug Metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes Neuropharmacology 2011, 60, 910-920.
1521
Gupta C, Tripathi DN, Vikram A, Ramarao P and Jena GB. Quercetin inhibits diethylnitrosamine-induced hepatic preneoplastic lesions in rats Nutrition and Cancer 2011, 63, 234-241.
1522
Gupta P, Garg P and Roy N. Comparative docking and CoMFA analysis of curcumine derivatives as HIV-1 Integrase inhibitors Molecular Diversity 2011, 15, 733-750.
1523
Gupta S and Mohan CG. 3D-Pharmacophore Model based Virtual Screening to Identify Dual-Binding Site and Selective Acetylcholinesterase Inhibitors Medicinal Chemistry Research 2011, 20, 1422-1430.
1524
Gupta S, Fallarero A, Jarvinen P, Karlsson D, Johnson MS, Vuorela PM and Mohan CG. Discovery of dual binding site acetylcholinesterase inhibitors identified by pharmacophore modeling and sequential virtual screening techniques Bioorganic & Medicinal Chemistry Letters 2011, 21, 1105-1112.
1525
Gupta S, Fallarero A, Vainio MJ, Saravanan P, Puranen JS, J rvinen P, Johnson MS, Vuorela PM and Mohan CG. Molecular Docking Guided Comparative GFA, G/PLS, SVM and ANN Models of Structurally Diverse Dual Binding Site Acetylcholinesterase Inhibitors Molecular Informatics 2011, 30, 689-706.
1526
Harde H, Das M and Jain S. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle Expert Opinion on Drug Delivery 2011, 8, 1407-1424.
1527
Harrison JA, Kartha KPR, Fournier EJL, Lowary TL, Malet C, Nilsson UJ, Hindsgaul O, Schenkman S, Naismith JH and Field RA. Probing the acceptor substrate binding site of Trypanosoma cruzi transsialidase with systematically modified substrates and glycoside libraries Organic & Biomolecular Chemistry 2011, 9, 1653-1660.
1528
Jachak SM, Gautam R, Selvam C, Madhan H, Srivastava A and Khan T. Anti-inflammatory, cyclooxygenase inhibitory and antioxidant activities of standardized extracts of Tridax procumbens L Fitoterapia 2011, 82, 173-177.
1529
Jain AK, Swarnakar NK, Das M, Godugu C, Singh RP, Rao PR and Jain S. Augmented Anticancer Efficacy of Doxorubicin-Loaded Polymeric Nanoparticles after Oral Administration in a Breast Cancer Induced Animal Model Molecular Pharmaceutics 2011, 8, 1140-1151.
1530
Jain AK, Swarnakar NK, Godugu C, Singh RP and Jain S. The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen Biomaterials 2011, 32, 503-515.
Information: Duration to be uploaded/incorporated on archival site after the completion of process is 12 months.

2627|102|15